Kieko Kobayashi Hara

Has grant

Postdoctoral Fellow

The University of Texas MD Anderson Cancer Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Evolution of Individual Patient's Tumor Immune Microenvironment in the Development of Clear Cell Renal Cell Carcinoma

Open Date: 2020-10-01

Close Date: 2021-09-01

Grant: Close

Discovery of biomarkers for refractory and immune related adverse event of anti-PD-1 antibody therapy in lung adenocarcinoma

Open Date: 2018-04-01

Close Date: 2020-03-31

Articles (10)

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (2)

Jerry W. Shay

Professor

University of Texas Southwestern Medical Center

UNITED STATES

View details

Seyed Javad Moghaddam

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kieko Kobayashi Hara

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (10)

CALML5 is a novel diagnostic marker for differentiating thymic squamous cell carcinoma from type B3 thymoma

Clinical relevance of PD-L2 expression in surgically resected lung adenocarcinoma

Single-Cell Expression Landscape of SARS-CoV-2 Receptor <i>ACE2</i> and Host Proteases in Normal and Malignant Lung Tissues from Pulmonary Adenocarcinoma Patients

Augmented Lipocalin-2 Is Associated with Chronic Obstructive Pulmonary Disease and Counteracts Lung Adenocarcinoma Development

Definitive radiotherapy in lieu of systemic therapy for oligometastatic renal cell carcinoma: a single-arm, single-centre, feasibility, phase 2 trial

Diffuse expression of MUC6 defines a distinct clinicopathological subset of pulmonary invasive mucinous adenocarcinoma

Histological characteristics of lung adenocarcinoma with uncommon actionable alterations: special emphasis on MET exon 14 skipping alterations

Programmed death-ligand 1 expression and its associations with clinicopathological features, prognosis, and driver oncogene alterations in surgically resected lung adenocarcinoma

Resolving the spatial and cellular architecture of lung adenocarcinoma by multiregion single-cell sequencing

Clinicopathological characteristics of lung adenocarcinoma with compound EGFR mutations

Collaborators (2)

Jerry W. Shay

Seyed Javad Moghaddam

Make your next move.